Natco Pharma Ltd. (NATCOPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 156274, "name": "Natco Pharma", "stock_name": "Natco Pharma", "full_name": "Natco Pharma Ltd.", "name_url": "stocks-analysis/natco-pharma", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "819.25", "chg": -20.65, "chgp": "-2.46%", "dir": -1, "prev_price": "839.90", "mcapval": "14,673.58 Cr", "mcap": "Small Cap", "scripcode": 524816, "symbol": "NATCOPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE987B01026", "curr_date": "Feb 13", "curr_time": "", "bse_nse_vol": "5.34 lacs", "exc_status": "Active", "traded_date": "Feb 13, 2026", "traded_date_str": "2026 02 13", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Natco Pharma Ltd. Reports Sharp Decline in Quarterly Performance Amid Margin Contraction", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-reports-sharp-decline-in-quarterly-performance-amid-margin-contraction-3836333", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_fintrenddot_3836333.png", "date": "2026-02-13 08:00:12", "description": "Natco Pharma Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has reported a significant downturn in its latest quarterly financial performance, with revenue and profit metrics sharply contracting compared to historical averages. The company’s financial trend has shifted from flat to negative, prompting a downgrade in its Mojo Grade from Buy to Hold as of 12 January 2026." }, { "title": "Are Natco Pharma Ltd. latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-natco-pharma-ltd-latest-results-good-or-bad-3835697", "imagepath": "", "date": "2026-02-12 19:45:21", "description": "Natco Pharma Ltd. has reported its financial results for the quarter ended December 2025, which reveal significant operational challenges. The company experienced a substantial sequential decline in both net sales and net profit, with net sales dropping to ₹647.30 crores, reflecting a 52.51% contraction from the previous quarter's ₹1,363.00 crores. Similarly, net profit fell sharply to ₹151.50 crores, marking a 70.78% decrease compared to ₹518.40 crores in the prior quarter. \n\nDespite these challenges, the year-on-year figures present a more favorable picture, with net sales showing a 36.33% increase from ₹474.80 crores in Q3 FY25, and net profit rising by 13.91% from the same period last year. This suggests that while the current quarter's performance is concerning, it is somewhat mitigated by the context of a weaker prior year.\n\nThe operating margin, excluding other income, also saw a significant contract..." }, { "title": "Natco Pharma Q3 FY26: Sharp Revenue Decline Masks Underlying Volatility", "link": "https://www.marketsmojo.com/news/result-analysis/natco-pharma-q3-fy26-sharp-revenue-decline-masks-underlying-volatility-3835512", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharma_quaterlyResult_3835512.png", "date": "2026-02-12 17:31:03", "description": "Natco Pharma Ltd., the Hyderabad-based pharmaceutical company with a market capitalisation of ₹15,154 crores, reported consolidated net profit of ₹151.50 crores for Q3 FY26 (October-December 2025), marking a sharp 70.78% decline quarter-on-quarter from ₹518.40 crores in Q2 FY26. Year-on-year, profits rose 13.91% from ₹133.00 crores in Q3 FY25, though this comparison is complicated by the highly volatile quarterly performance pattern that has characterised the company's recent financial trajectory." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3829500", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_technicaldot_3829500.png", "date": "2026-02-10 08:00:30", "description": "Natco Pharma Ltd. has experienced a subtle yet notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. Despite this positive tilt, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential upside. This article analyses the recent price momentum, key technical indicators including MACD, RSI, moving averages, and their implications for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Natco Pharma Declines 1.46%: Mixed Technical Signals Shape Weekly Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-declines-146-mixed-technical-signals-shape-weekly-performance-3827503", "imagepath": "", "date": "2026-02-08 15:02:15", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>3 Feb:</strong> Strong gap up opening, reflecting positive market sentiment</p>\n <p><strong>6 Feb:</strong> Technical momentum shifts again, signalling mildly bearish stance</p>\n <p><strong>Week Close:</strong> Rs.823.25 (-1.46%) vs Sensex +1.51%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.835.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-va..." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3823496", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_technicaldot_3823496.png", "date": "2026-02-06 08:00:17", "description": "Natco Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early February 2026. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively suggest a cautious outlook for investors amid volatile price action." }, { "title": "Natco Pharma Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-by-marketsmojo-3820459", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_mojoScore_3820459.png", "date": "2026-02-04 10:10:04", "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Natco Pharma Ltd. Opens with Strong Gap Up, Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3817730", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_gapup_3817730.png", "date": "2026-02-03 09:43:37", "description": "Natco Pharma Ltd. commenced trading on 3 Feb 2026 with a notable gap up, opening 6.87% higher than its previous close, reflecting a robust start and positive market sentiment within the Pharmaceuticals & Biotechnology sector." }, { "title": "Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3815221", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NatcoPharmaLtd_technicaldot_3815221.png", "date": "2026-02-02 08:00:24", "description": "Natco Pharma Ltd. has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend as of early February 2026. This change is underscored by a complex interplay of technical indicators, including bearish MACD and Bollinger Bands on weekly and monthly charts, alongside a mildly bullish daily moving average and a mixed RSI profile. Investors should carefully analyse these signals amid the company’s recent price performance and sector dynamics." } ], "total": 5601, "sid": "156274", "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "03-Feb-2026", "details": "NATCO receives Tentative Approval for Erdafitinib Tablets (generic of Balversa)", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "03-Feb-2026", "details": "Natco Receives Tentative Approval for Erdafitinib Tables (generic of Balversa) from the United States Food and Drug Administration (U.S.FDA)", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "02-Feb-2026", "details": "Intimation of Q3FY26 Un-audited Financial Results Earnings Call", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 20 Nov 25", "dt": "2025-11-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15", "dt": "2015-11-26", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Technical momentum shifts amid mixed indicator signals

3 Feb: Strong gap up opening, reflecting positive market sentiment

6 Feb: Technical momentum shifts again, signalling mildly bearish stance

Week Close: Rs.823.25 (-1.46%) vs Sensex +1.51%

Week Open

Rs.835.45

Week Close

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-06 08:00:17

Natco Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early February 2026. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively suggest a cautious outlook for investors amid volatile price action.

Read full news article

Natco Pharma Ltd. is Rated Hold by MarketsMOJO

2026-02-04 10:10:04

Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Natco Pharma Ltd. Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 09:43:37

Natco Pharma Ltd. commenced trading on 3 Feb 2026 with a notable gap up, opening 6.87% higher than its previous close, reflecting a robust start and positive market sentiment within the Pharmaceuticals & Biotechnology sector.

Read full news article

Natco Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-02 08:00:24

Natco Pharma Ltd. has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend as of early February 2026. This change is underscored by a complex interplay of technical indicators, including bearish MACD and Bollinger Bands on weekly and monthly charts, alongside a mildly bullish daily moving average and a mixed RSI profile. Investors should carefully analyse these signals amid the company’s recent price performance and sector dynamics.

Read full news article